Challenging the Medicalization of Sex




Click to learn more and to purchase this and other books.

NVC in the Press - 2014

Select a year:

Title: Do Women Need Their Own Viagra?
Date: 12/18/2014
Description: Long and thorough, though typical, analysis of FSD situation with lots of links to other pieces. Probably good for students.
Author: Jacoba Urist
Source: The Atlantic
URL: visit link

Title: How the sexual pharmaceutical industry tried to hijack the FDA
Date: 12/2/2014
Description: OpEd by Vancouver sociologist and New Viewer Thea Cacchioni describing her experiences at the October FDA meeting
Author: Thea Cacchioni
Source: (Vancouver)
URL: visit link

Title: FDA should not approve sex drug for women
Date: 12/1/2014
Description: Op-Ed by Karen Hicks of the NVC on her experiences at the October 27, 2014 FDA meeting.
Author: Karen Hicks
Source: Allentown Morning Call
URL: visit link

Title: Pink Viagra: Sex for Pleasure, for Profit, or Both?
Date: 11/24/2014
Description: Seems critical of "distortions" in L.A.Times op-ed, though says he agrees with all the points. However, takes issue with NVC slogan "sex for our pleasure or their profit?" Seems to feel you can have both!
Author: Stephen Snyder
Source: Psychology Today blog
URL: visit link

Title: Multi-million dollar race to find a pink Viagra
Date: 11/22/2014
Description: Comprehensive and well-researched Australian overview of the pink Viagra story, including the "Even the Score" campaign and runup to the FDA meeting.
Author: Julia Medew
Source: Sydney Morning Herald (Australia)
URL: visit link

Title: Why Doesn't a Viagra Equivalent Exist for Women?
Date: 11/19/2014
Description: Excellent overview of FDA hearing with many links to original documents. Good mention of NVC and allies.
Author: Rachel Waldon
Source: Our Bodies Our Blog
URL: visit link

Title: Is Pink Viagra a 'Sham Drug'? Top Experts Think So
Date: 11/18/2014
Description: Coverage of L.A. Times op-ed. Asks sexologist Debby Herbenick of Kinsey to vet the claims, and she supports them.
Author: Amy Rushlow
Source: Yahoo Health Online
URL: visit link

Title: The drug companies that are using feminism against you
Date: 11/16/2014
Description: Feminist writes support of our op-ed in the Los Angeles Times
Author: Miri Forbes
Source: Daily blog
URL: visit link

Title: Viagra for Women: Medical Miracle or Snake Oil?
Date: 11/14/2014
Description: Good coverage of Los Angeles Times op-ed and "Even the Score" campaign.
Author: Kate Dries
Source: Jezebel online
URL: visit link

Title: The FDA Hesitation to Approve Female Sexual Dysfunction Drugs Is not About Sexism
Date: 11/13/2014
Description: Lengthy analysis of Myths and Facts about Sprout Pharmaceutical's "Even the Score" campaign to blame FDA for failure to approve FSD drugs
Author: Coco Jervis
Source: Rewire Reality Check
URL: visit link

Title: Op-Ed: The sham drug idea of the year: 'pink Viagra'
Date: 11/13/2014
Description: Op-Ed in the Los Angeles Times criticizing and exposing the "Even the Score" campaign sponsored by Sprout Pharmaceuticals. Only the 2nd major op-ed in New View history - big media response, as well as vitriol from "Even the Score" supporters.
Author: Ellen Laan and Leonore Tiefer
Source: Los Angeles Times
URL: visit link

Title: FDA ponders female low-libido drug. Again.
Date: 10/30/2014
Description: Solid overview of FDA hearing on female sexual dysfunction. Contact Philly Inquirer for full article.
Author: Marie McCullough
Source: Philadelphia Inquirer
URL: visit link

Title: Lehigh University professor urges caution in federal review of sexual drugs for women
Date: 10/27/2014
Description: Coverage of Day 1 of FDA hearing on female sexual dysfunction featuring interview with NVC Karen Hicks
Author: Laura Olson
Source: Allentown Morning Call
URL: visit link

Title: The Voice of the Patient: FDA Public Workshop on Female Sexual Dysfunction
Date: 10/27/2014
Description: A series of reports from the U.S. Food and Drug Administration patient- focused drug development initiative on FSD.
Source: FDA
URL: visit link

Title: Women Press FDA to Encourage Sexual Dysfunction Drugs
Date: 10/27/2014
Description: Coverage of day 1 of the FDA meeting on female sexual dysfunction. Reporter gives accurate depiction of the patients, what they said, and who paid them to attend. Contact WSJ for full article.
Author: Thomas Burton
Source: Wall Street Journal
URL: visit link

Title: Big Pharma Urges Women to Fight for Access to Harmful Pill
Date: 10/27/2014
Description: Thorough look at "Even the Score" campaign, with quotes from Cacchioni, Hicks, and Moynihan. One of the few pieces to actually go into medicalization as it refutes "Even the Score."
Author: Mara Kardas-Nelson
Source: Truth-Out investigative online
URL: visit link

Title: Evening the score on sex drugs: feminist movement or marketing masquerade?
Date: 10/17/2014
Description: 20 minute audio interview. Investigative reporter shows "Even the Score" supporters clueless about flibanserin science and rely on Sprout-paid consultants. Essential piece.
Author: Ray Moynihan
Source: British Medical Journal
URL: visit link

Title: Is the FDA Sexist? Regulators Pressed to OK Drugs for Female Sex Problem
Date: 7/8/2014
Description: Wall Street Journal challenges the facts behind Sprout Pharmaceuticals' "Even the Score" campaign
Author: Ed Silverman
Source: Wall Street Journal blog
URL: visit link

Title: Advocates crusade for gender equality in treating sexual dysfunction
Date: 7/7/2014
Description: Coverage and criticism of the "Even the Score" PR campaign by Sprout Pharmaceuticals that claims FSD drugs are denied because of "gender bias" at the FDA.
Author: Marie McCullough
Source: Philadelphia Inquirer
URL: visit link

Title: Waking up to the Medicalization of Sex
Date: 6/20/2014
Description: Strong, brief 4-page personal introduction to the medicalization of sex and New View activism.
Author: Leonore Tiefer
Source: Hysteria Issue #3
URL: visit link

Title: How to handle FDA rejection
Date: 4/6/2014
Description: Investigation of the campaign engineered by Sprout Pharmaceutical company to challenge the false gender bias at FDA that inhibited approval of FSD drugs.
Author: Paul Thacker
Source: Slate
URL: visit link

1 to 21 of 21 records.